Antares Pharma, Inc. (ATRS)

Cost of Revenue

$18.77M

Quarterly · Period ending: · USD

ATRS logo

ATRS Cost of Revenue

Latest reported$18.77M
ATRS Quarterly Cost of Revenue ($0.00 → $18.77M)
High-resolution chart · PNG

ATRS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
18,767,000
18,967,000
16,429,000
16,440,000
16,445,000
19,059,000
16,517,000
12,477,000
15,047,000
14,026,000
13,062,000
12,441,000
10,946,000
9,630,000
7,289,000
6,960,000
7,186,000
7,106,948
8,522,897
5,616,389
6,219,766
6,689,206
8,033,721
7,318,098
6,775,741
5,975,097
5,099,763
4,708,094
3,674,729
5,422,504
2,507,366
2,130,080
1,176,745
684,803
3,004,602
3,480,682
2,027,143
1,702,041
3,296,489
2,531,111
1,990,831
2,144,012
1,807,050
1,393,289
1,452,841
882,756
1,079,514
995,961
1,314,979
1,595,143
1,212,194
620,642
711,855
436,850
595,978
534,709
452,048
1,855,097
551,640
567,731
467,552
483,559
319,698
431,224
321,488
261,050
299,882
268,325
307,488
358,346
265,673
402,800
345,483
394,433
541,893
569,081
502,476
478,197
874,374
559,285
661,424
769,839
373,190
426,054
277,714
417,009
344,210
563,799
321,571
885,464
300,000
200,000
400,000
652,026
400,000
400,000
400,000
621,051
200,000
300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.